Table 2.

Comparison of fees charged and source of funding in 2019.

Country	Mozambique	Namibia	South Africa	Tanzania	Zambia	Zimbabwe
Source of funding*	Large % government,	100% government	70% government	12% government;	95% fees	100% fees
	small % other sources		30% Fees	76% fees; 12% other	5% other
Fees for review of a new chemical entity (USD)	360	333	3,558	2,000	2,800	3,000
Fees for review of biologicals (USD)	360	333	2,833	3,500	2,800	3,000
Fees for review of generics (USD)	350	333	1,781	2,000	2,000	2,500

^*Actual percentages vary year to year.